Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18896954 | 3D PRINTED BONE DEFECT REPAIR SCAFFOLD LOADED WITH EXTRACELLULAR MATRIX OF MESENCHYMAL STEM CELLS AND PREPARATION METHOD THEREOF | September 2024 | May 2025 | Abandon | 8 | 1 | 0 | No | No |
| 18841788 | DOUBLE-CROSSLINKED FIBRIN GEL, RAW MATERIAL COMPOSITION AND KIT THEREOF, AND APPLICATION THEREOF | August 2024 | June 2025 | Allow | 9 | 1 | 0 | No | No |
| 18811158 | METHODS FOR FIXING HAIR AND SKIN | August 2024 | November 2024 | Allow | 3 | 1 | 0 | No | No |
| 18766716 | METHOD FOR TREATING CANCER CELLS WITH A CU/AG PARTICLE COMPOSITION | July 2024 | September 2024 | Allow | 2 | 0 | 0 | Yes | No |
| 18643595 | TOPICAL PHARMACEUTICAL COMPOSITIONS | April 2024 | August 2024 | Allow | 4 | 1 | 0 | No | No |
| 18624746 | BIOLOGIC MATRIX FOR A WOUND SITE AND RELATED METHODS | April 2024 | September 2024 | Allow | 5 | 1 | 0 | No | No |
| 18616089 | Methods of treating or reducing symptoms of brain cancer such as glioma and glioblastoma via combination therapy with allosteric modulators and phenethylamines. | March 2024 | June 2025 | Abandon | 15 | 2 | 1 | No | No |
| 18607763 | FISH-DERIVED PEPTIDOGLYCAN RECOGNITION PROTEIN MUTANTAND APPLICATION THEREOF | March 2024 | August 2024 | Allow | 5 | 1 | 0 | No | No |
| 18606551 | CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING STABILIZERS OF LABILE COMPONENTS SUCH AS DRUGS | March 2024 | August 2024 | Allow | 5 | 0 | 1 | No | No |
| 18602710 | MULTISTAGE CALCINATION METHOD FOR MAKING HOLLOW SILICA SPHERES | March 2024 | August 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18599582 | METHOD FOR DECREASING COLORECTAL CANCER CELLS | March 2024 | June 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18583657 | METHODS FOR RAISING NITRIC OXIDE AND REDUCTION OF URIC ACID | February 2024 | March 2025 | Abandon | 13 | 2 | 0 | No | No |
| 18435068 | SOLANUM LYCOPERSICUM SEED OIL FREEZE-DRIED POWDER WITH WHITENING EFFICACY, COMPOSITION, AND PREPARATION METHOD AND APPLICATION THEREOF | February 2024 | June 2025 | Allow | 16 | 2 | 1 | No | No |
| 18432437 | POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION | February 2024 | May 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18414445 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | January 2024 | March 2024 | Allow | 2 | 0 | 0 | No | No |
| 18414442 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | January 2024 | May 2024 | Allow | 4 | 0 | 1 | No | No |
| 18545415 | SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NEUROTROPHIC AND NEUROPROTECTIVE COMPOSITIONS | December 2023 | April 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18542059 | BONE REGENERATION MATERIAL HAVING A COTTON-WOOL LIKE STRUCTURE FORMED OF A PLURALITY OF ELECTROSPUN FIBERS | December 2023 | February 2025 | Abandon | 14 | 1 | 1 | No | No |
| 18541054 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | December 2023 | February 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18527884 | USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS | December 2023 | March 2025 | Allow | 15 | 1 | 0 | No | No |
| 18525495 | SOLID HAND AND BODY LOTION PELLETS | November 2023 | August 2024 | Abandon | 8 | 1 | 0 | No | No |
| 18506493 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | November 2023 | June 2024 | Allow | 7 | 1 | 0 | No | No |
| 18503232 | Combination and Uses and Treatments Thereof | November 2023 | April 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18386758 | METHOD OF TREATING A GLAZED CERAMIC ARTICLE | November 2023 | April 2025 | Allow | 18 | 0 | 0 | No | No |
| 18386411 | ETHYL 2-[9-(6-FLOURO-2-HYDROXYQUINOLIN-3-YL)-1,8-DIOXO-3,4,9,10-TETRAHYDROACRIDINE-10-YL]-ACETATE AS AN ANTIMICROBIAL COMPOUND | November 2023 | February 2024 | Allow | 3 | 0 | 0 | No | No |
| 18382887 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | October 2023 | March 2024 | Allow | 5 | 1 | 1 | No | No |
| 18379598 | Botanical Film-Forming Acne Compositions | October 2023 | June 2025 | Allow | 20 | 1 | 0 | No | No |
| 18555193 | USE IN AN AQUEOUS-ALCOHOLIC COMPOSITION OF POLYMERS OBTAINED BY LOW-CONCENTRATION INVERSE EMULSION POLYMERISATION WITH LOW NEUTRALISED MONOMER LEVEL | October 2023 | November 2024 | Abandon | 14 | 1 | 1 | No | No |
| 18483098 | FREEZE-DRIED ARIPIPRAZOLE FORMULATION | October 2023 | January 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18374334 | HOLLOW SILICA SPHERES WITH NESTED IRON OXIDE PARTICLES | September 2023 | February 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18475634 | SURFACE ZWITTERIONIZED SILICONE ANTIFOULING COATING AND PREPARATION METHOD THEREOF | September 2023 | March 2025 | Abandon | 17 | 2 | 1 | No | No |
| 18465918 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | September 2023 | August 2024 | Abandon | 11 | 1 | 1 | No | No |
| 18242099 | Micronutrient composition to improve men health | September 2023 | March 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18456072 | WHITE PIGMENT FOR COSMETICS, AND COSMETIC | August 2023 | November 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18236612 | BIO-BASED MOISTURE ABSORPTION AND SWEAT DISCHARGING MULTIFUNCTIONAL FINISHING AGENT AND PREPARATION METHOD AND APPLICATION THEREOF | August 2023 | February 2024 | Allow | 6 | 0 | 1 | No | No |
| 18236278 | COMPOSITION FOR PREVENTING ADHESION OF AIR-BORNE FINE PARTICLES | August 2023 | April 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18448259 | BIOLOGIC MATRIX FOR A WOUND SITE AND RELATED METHODS | August 2023 | April 2024 | Allow | 8 | 1 | 1 | No | No |
| 18448754 | FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM | August 2023 | August 2024 | Abandon | 12 | 2 | 0 | Yes | No |
| 18448640 | FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM | August 2023 | February 2025 | Abandon | 18 | 3 | 0 | Yes | No |
| 18231862 | NANOCOMPOSITE COMPOSITIONS COMPRISING MULTI-VALENT METAL MATERIAL AND IMMOBILIZED QUAT MATERIAL, METHODS OF MAKING THE COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS | August 2023 | February 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18366927 | SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR PHARMACEUTICAL COMPOSITIONS | August 2023 | January 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18366945 | SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS | August 2023 | January 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18230766 | TOPICAL COMPOSITIONS INCORPORATING SILICA FIBERS | August 2023 | June 2025 | Allow | 22 | 2 | 1 | Yes | No |
| 18355618 | MODIFIED RELEASE FORMULATION | July 2023 | June 2025 | Abandon | 23 | 4 | 1 | No | No |
| 18222641 | PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES | July 2023 | January 2025 | Abandon | 18 | 1 | 1 | No | No |
| 18220599 | COMPOSITION FOR TREATING BONE LOSS | July 2023 | January 2025 | Abandon | 18 | 3 | 0 | No | No |
| 18220560 | COMPOSITION FOR TREATING BONE LOSS | July 2023 | May 2025 | Abandon | 23 | 4 | 0 | No | No |
| 18349570 | EPHEDRINE LIQUID FORMULATIONS | July 2023 | May 2025 | Abandon | 22 | 1 | 1 | No | No |
| 18349753 | BIOLOGICALLY ACTIVE SUBSTANCE UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME | July 2023 | February 2025 | Abandon | 20 | 1 | 1 | No | No |
| 18218312 | Simplified Method for Making Shelf Stable Highly Water Soluble Anhydrous Compositions Of Cyclodextrin Complexes of Macrocyclic Lactones | July 2023 | August 2024 | Abandon | 14 | 2 | 1 | Yes | No |
| 18345770 | NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERY | June 2023 | March 2025 | Allow | 20 | 1 | 0 | No | No |
| 18343812 | CANCER TREATING COMPOSITION CONTAINING COPPER-SILVER-PHOSPHATE NANOPARTICLES | June 2023 | May 2025 | Allow | 23 | 3 | 1 | Yes | No |
| 18343803 | COPPER-SILVER-PHOSPHATE NANOPARTICLE MANUFACTURING METHOD | June 2023 | January 2025 | Allow | 19 | 1 | 1 | No | No |
| 18259697 | TRANSDERMAL PSYCHOACTIVE ALKALOID COMPOSITION AND PREPARATION THEREOF | June 2023 | April 2024 | Allow | 9 | 1 | 1 | No | No |
| 18269341 | HAIR CARE COMPOSITION | June 2023 | October 2024 | Abandon | 16 | 2 | 1 | No | No |
| 18339800 | COMPOSITIONS FOR COATING EDIBLE SUBSTRATES AND METHODS OF MAKING AND USING THE SAME | June 2023 | June 2025 | Abandon | 24 | 2 | 0 | No | No |
| 18257531 | RESIN BEADS, METHOD FOR PRODUCING RESIN BEADS, AND PRODUCT USING RESIN BEADS | June 2023 | September 2024 | Allow | 15 | 1 | 1 | Yes | No |
| 18332194 | TRANSDERMAL ADHESIVE COMPOSITION COMPRISING A POORLY SOLUBLE THERAPEUTIC AGENT | June 2023 | September 2024 | Abandon | 16 | 1 | 0 | No | No |
| 18332434 | Composition Containing a Cellulose Derived Capsule With a Sunscreen | June 2023 | May 2025 | Abandon | 23 | 2 | 0 | No | No |
| 18207289 | COMPOSITE SOLS | June 2023 | May 2025 | Abandon | 23 | 1 | 0 | No | No |
| 18329422 | COMPOUND, PRODUCTION METHOD THEREFOR, AND HYDROGEN SUPPLY METHOD | June 2023 | January 2025 | Abandon | 19 | 1 | 0 | No | No |
| 18254976 | PERSONAL CARE COMPOSITIONS | May 2023 | October 2024 | Abandon | 16 | 2 | 1 | No | No |
| 18254286 | METHOD FOR PREPARATION OF EFFERVESCENT GRANULES | May 2023 | September 2024 | Allow | 16 | 2 | 0 | No | No |
| 18200055 | HOLLOW SILICA SPHERES WITH NESTED IRON OXIDE PARTICLES | May 2023 | August 2024 | Allow | 14 | 1 | 0 | Yes | No |
| 18253766 | CONTROLLED ENTRAPMENT AND RELEASE OF MOLECULAR CARGO | May 2023 | June 2024 | Allow | 13 | 1 | 1 | Yes | No |
| 18318647 | FORMULATIONS AND METHODS FOR TREATING HAIR | May 2023 | December 2024 | Allow | 19 | 3 | 1 | Yes | No |
| 18144859 | TISSUE ADHESIVE MEMBRANE AND PREPARATION METHOD THEREOF | May 2023 | June 2024 | Allow | 14 | 2 | 1 | Yes | No |
| 18312445 | SYSTEMS AND METHODS FOR BONE REPAIR AND MANAGEMENT USING BIOCOMPATIBLE POLYMERIC RESIN | May 2023 | September 2024 | Abandon | 16 | 1 | 1 | No | No |
| 18307378 | ERODIBLE ANHYDROUS POLYETHYLENE OXIDE FILM | April 2023 | April 2025 | Abandon | 23 | 1 | 0 | No | No |
| 18139095 | TABLET CONTAINING VALSARTAN AND SACUBITRIL | April 2023 | December 2024 | Abandon | 20 | 1 | 1 | Yes | No |
| 18302975 | CONTROLLING NEUROPATHIC PAIN | April 2023 | September 2024 | Allow | 17 | 1 | 0 | No | No |
| 18302726 | DELIVERY OF COSMETIC AGENTS, COMPOSITIONS AND USE THEREOF | April 2023 | April 2025 | Abandon | 24 | 2 | 0 | No | No |
| 18301505 | METHOD FOR KILLING COLORECTAL CANCER CELLS | April 2023 | November 2024 | Allow | 19 | 2 | 0 | Yes | No |
| 18133349 | AQUEOUS FORMULATIONS OF TOPIRAMATE | April 2023 | February 2025 | Allow | 22 | 3 | 1 | No | No |
| 18296270 | MACROGOL 15 HYDROXYSTEARATE FORMULATIONS | April 2023 | April 2025 | Abandon | 24 | 0 | 1 | No | No |
| 18130478 | ANTI-AGING COMPOSITION BASED ON MIXED ESTER OF STILBENIC EXTRACT | April 2023 | September 2023 | Allow | 5 | 1 | 1 | No | No |
| 18126221 | LIQUID PHARMACEUTICAL FORMULATIONS OF TOPIRAMATE | March 2023 | June 2024 | Allow | 15 | 2 | 0 | Yes | No |
| 18125551 | COMPOSITIONS AND USE OF VARENICLINE FOR TREATING DRY EYE | March 2023 | January 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18125562 | COMPOSITIONS AND USE OF VARENICLINE FOR TREATING DRY EYE | March 2023 | January 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18125517 | COMPOSITIONS AND USE OF VARENICLINE FOR TREATING DRY EYE | March 2023 | January 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18185696 | COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS | March 2023 | September 2024 | Allow | 18 | 1 | 1 | No | No |
| 18184797 | PHARMACEUTICAL COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE AND L-ACETYLCARNITINE | March 2023 | March 2025 | Allow | 24 | 2 | 1 | Yes | No |
| 18026658 | MOISTURIZING ANTIBACTERIAL COMPOSITION | March 2023 | May 2025 | Abandon | 26 | 4 | 1 | No | No |
| 18026633 | MOISTURIZING ANTIBACTERIAL COMPOSITION | March 2023 | May 2025 | Abandon | 26 | 4 | 1 | No | No |
| 18116820 | COMPOSITION FOR TREATING BONE LOSS | March 2023 | February 2025 | Abandon | 24 | 4 | 1 | No | No |
| 18114502 | LIQUID PHARMACEUTICAL COMPOSITIONS OF BACLOFEN FOR ORAL ADMINISTRATION | February 2023 | July 2024 | Abandon | 16 | 3 | 0 | Yes | No |
| 18113449 | CONFORMAL COATING OF CELLS FOR IMMUNOISOLATION | February 2023 | March 2025 | Allow | 24 | 1 | 0 | Yes | No |
| 18172403 | ANTI-INFECTION AND ANTI-TUMOR MUCOSAL IMMUNE PREPARATION | February 2023 | January 2025 | Abandon | 23 | 0 | 1 | No | No |
| 18169051 | CONTINUOUS RELEASE COMPOSITIONS MADE FROM HYALURONIC ACID, AND THERAPEUTIC APPLICATIONS OF SAME | February 2023 | October 2024 | Allow | 20 | 1 | 0 | No | No |
| 18108576 | METHOD OF MANUFACTURING SPRAY-DRIED POWDERS | February 2023 | May 2025 | Allow | 27 | 1 | 1 | No | No |
| 18167056 | FORMULATIONS OF PILOCARPINE AND BRIMONIDINE COMPOUNDS AND RELATED METHODS | February 2023 | August 2024 | Allow | 18 | 3 | 0 | No | No |
| 18107788 | PERACETIC ACID ANTIMICROBIAL COMPOSITION SYSTEM AND METHOD | February 2023 | January 2025 | Abandon | 23 | 2 | 1 | No | No |
| 18162259 | MICROPARTICLES CONTAINING BUPROPION | January 2023 | February 2024 | Abandon | 13 | 2 | 0 | Yes | No |
| 18103998 | UNIVERSAL MINERAL BASED SUNSCREEN AND RELATED METHODS OF MANUFACTURE | January 2023 | July 2024 | Allow | 18 | 2 | 1 | No | No |
| 18017734 | COSMETIC MASK FOR IMPROVING APPEARANCE OF SKIN | January 2023 | November 2024 | Abandon | 21 | 2 | 1 | No | No |
| 18098361 | SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS | January 2023 | November 2024 | Allow | 22 | 1 | 0 | No | No |
| 18155677 | GADUSOL-CONTAINING SUNSCREEN FORMULATIONS | January 2023 | September 2024 | Abandon | 20 | 2 | 1 | Yes | No |
| 18154470 | PHARMACEUTICALLY STABLE PILOCARPINE FORMULATIONS WITH SUBSTANTIALLY REDUCED BUFFER CONTENT AND RELATED METHODS | January 2023 | November 2024 | Abandon | 22 | 4 | 0 | No | No |
| 18005072 | NOVEL SPHINGOLIPID, AND DERMATOLOGIC COMPOSITION COMPRISING SAME FOR EXTERNAL APPLICATION | January 2023 | June 2025 | Allow | 29 | 0 | 0 | No | No |
| 18151604 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | January 2023 | April 2024 | Abandon | 15 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1619.
With a 22.2% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 17.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Art Unit 1619 is part of Group 1610 in Technology Center 1600. This art unit has examined 8,442 patent applications in our dataset, with an overall allowance rate of 37.3%. Applications typically reach final disposition in approximately 38 months.
Art Unit 1619's allowance rate of 37.3% places it in the 1% percentile among all USPTO art units. This art unit has a significantly lower allowance rate than most art units at the USPTO.
Applications in Art Unit 1619 receive an average of 2.72 office actions before reaching final disposition (in the 95% percentile). The median prosecution time is 38 months (in the 10% percentile).
When prosecuting applications in this art unit, consider the following:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.